Home
Reels
Groepen
Pagina
Kijk verder.....
Groepen Pagina Events Blogs Funding
Log in Creëer je account
Night Mode
How Are Disease-Modifying Biologics Transforming Pulmonary Arterial Hypertension Treatment?
For decades, PAH treatment relied on vasodilators that managed symptoms but did not address the underlying disease process. Disease-modifying biologics are transforming PAH treatment by targeting the vascular remodeling that drives disease progression, offering the potential for improved long-term outcomes. This innovation is a major driver of growth in the Pulmonary Arterial Hypertension...
0 Reacties ·0 aandelen ·135 Views ·0 voorbeeld
Please log in to like, share and comment!